BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4279 related articles for article (PubMed ID: 6643789)

  • 1. Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A.
    Marx JL; Auerbach R; Possick P; Myrow R; Gladstein AH; Kopf AW
    J Am Acad Dermatol; 1983 Dec; 9(6):904-11. PubMed ID: 6643789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study.
    Gupta AK; Stern RS; Swanson NA; Anderson TF
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):67-76. PubMed ID: 3403747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The occurrence of vitiligo after psoralens and ultraviolet a therapy.
    Todes-Taylor N; Abel EA; Cox AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):526-32. PubMed ID: 6630615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of melanoma in association with long-term exposure to PUVA.
    Stern RS;
    J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma and psoralens and ultraviolet A.
    Johnson J
    J Am Acad Dermatol; 1984 Jul; 11(1):143. PubMed ID: 6736351
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUVA treatment and skin cancer: A follow-up study.
    Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
    Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy.
    Weinstock MA; Coulter S; Bates J; Bogaars HA; Larson PL; Burmer GC
    Arch Dermatol; 1995 Jun; 131(6):701-4. PubMed ID: 7778923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes.
    Rhodes AR; Harrist TJ; Momtaz-T K
    J Am Acad Dermatol; 1983 Jul; 9(1):47-58. PubMed ID: 6411778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of PUVA and SUP therapy on nevocellular nevi (author's transl)].
    Pullmann H; Theunissen A; Galosi A; Steigleder GK
    Z Hautkr; 1981 Nov; 56(21):1412-7. PubMed ID: 7314762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PUVA lentigo: an analysis of predisposing factors.
    Rhodes AR; Stern RS; Melski JW
    J Invest Dermatol; 1983 Nov; 81(5):459-63. PubMed ID: 6631058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PUVA on the epidermal melanocyte population in psoriatic patients.
    Rosdahl IK; Swanbeck G
    Acta Derm Venereol; 1980; 60(1):21-6. PubMed ID: 6153829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical pigmented lesions following extensive PUVA therapy.
    Basarab T; Millard TP; McGregor JM; Barker JN
    Clin Exp Dermatol; 2000 Mar; 25(2):135-7. PubMed ID: 10733639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
    Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
    Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated superficial actinic porokeratosis: appearance associated with photochemotherapy for psoriasis.
    Hazen PG; Carney JF; Walker AE; Stewart JJ; Engstrom CW
    J Am Acad Dermatol; 1985 Jun; 12(6):1077-8. PubMed ID: 4008702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous and ocular side-effects of PUVA photochemotherapy--a 10-year follow-up study.
    Abdullah AN; Keczkes K
    Clin Exp Dermatol; 1989 Nov; 14(6):421-4. PubMed ID: 2691134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy.
    Frenk E
    Dermatologica; 1983; 167(3):152-4. PubMed ID: 6414855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 214.